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Abstract
Objective: Noncompliance with scheduled ambulatory saliva sampling is common and has been associated with biased
cortisol estimates in nonpregnant subjects. This study is the first to investigate in pregnant women strategies to improve
ambulatory saliva-sampling compliance, and the association between sampling noncompliance and saliva cortisol
estimates.
Methods: We instructed 64 pregnant women to collect eight scheduled saliva samples on two consecutive days each.
Objective compliance with scheduled sampling times was assessed with a Medication Event Monitoring System and self-
reported compliance with a paper-and-pencil diary. In a randomized controlled study, we estimated whether a disclosure
intervention (informing women about objective compliance monitoring) and a reminder intervention (use of acoustical
reminders) improved compliance. A mixed model analysis was used to estimate associations between women’s objective
compliance and their diurnal cortisol profiles, and between deviation from scheduled sampling and the cortisol
concentration measured in the related sample.
Results: Self-reported compliance with a saliva-sampling protocol was 91%, and objective compliance was 70%. The
disclosure intervention was associated with improved objective compliance (informed: 81%, noninformed: 60%), F(1,60)
= 17.64, p,0.001, but not the reminder intervention (reminders: 68%, without reminders: 72%), F(1,60) = 0.78, p= 0.379.
Furthermore, a woman’s increased objective compliance was associated with a higher diurnal cortisol profile, F(2,64) = 8.22,
p,0.001. Altered cortisol levels were observed in less objective compliant samples, F(1,705) = 7.38, p= 0.007, with delayed
sampling associated with lower cortisol levels.
Conclusions: The results suggest that in pregnant women, objective noncompliance with scheduled ambulatory saliva
sampling is common and is associated with biased cortisol estimates. To improve sampling compliance, results suggest
informing women about objective compliance monitoring but discourage use of acoustical reminders.
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Introduction
Maternal stress during pregnancy can adversely affect birth
outcomes and offspring development (e.g. [1,2]). Cortisol as a
stress marker, released by the maternal hypothalamic–pituitary–
adrenal (HPA) axis, may partly explain these effects (for reviews
see [3–6]). Therefore, psychoneuroendocrine research examining
cortisol in pregnant women has been given high priority and may
contribute to a better understanding of the biochemical mecha-
nism underlying the adverse effects described above [4]. Research
examining cortisol in pregnant women may also improve risk
assessment for adverse birth outcomes [7,8].
In ambulatory settings, cortisol concentrations are commonly
assessed noninvasively in saliva. Subjects are instructed to collect a
certain number of saliva samples at scheduled sampling times on
one or more consecutive study days [9–11]. Compared to
laboratory research, ambulatory research results in higher
ecological validity [12]. However, ambulatory saliva sampling
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may be biased by noncompliance: Subjects may not follow
scheduled sampling times and may fail to self-report this
noncompliance in paper-and-pencil diaries – even if study
collaborators stress the importance of both requirements. Indeed,
such patterns have been observed in studies using hidden
electronic compliance-monitoring systems, comparing subjects’
objective compliance to their self-reported compliance [13–15].
Noncompliance with scheduled saliva-sampling times has been
associated with biased cortisol estimates due to the cortisol
circadian rhythm [13,14,16]. Biased estimates of cortisol concen-
trations may cause invalid interpretations of the data. In contrast,
Jacobs et al. [15] reported no biased cortisol estimates when
noncompliant saliva samples were included in analyses. Saliva-
sampling noncompliance has also been associated with additional
study costs and, in the case of missing samples, with reduced
statistical power [17].
To deal with the compliance problem, experimental studies
tested whether informing subjects about objective compliance
monitoring improves compliance with scheduled saliva sampling.
In these studies, subjects who were informed about monitoring
displayed higher compliance with the sampling protocols
compared to noninformed subjects [13,14]. Acoustical reminders
such as preprogrammed wristwatches have been used to improve
saliva sampling compliance [18,19], although, to our knowledge,
their effect on saliva-sampling compliance has not yet been
experimentally tested, and experimental evidence that they
improve compliance comes from other research fields only: For
example, in a review, reminders improved medication compli-
ance in antiretroviral therapy in four of eight studies [20].
Moreover, electronic reminders improved participants’ compli-
ance with paper pain diaries, but still, according to Broderick
and colleagues [21], the compliance rates were unsatisfactory.
In sum, ambulatory saliva sampling has gained great impor-
tance in psychoneuroendocrine research, being used to examine
cortisol concentrations in pregnant women. However, findings
that noncompliance with saliva sampling is common and can bias
cortisol estimates, and that informing subjects about objective
compliance monitoring improves saliva-sampling compliance, are
based on ambulatory research in healthy volunteers, patients, and
an older population [13,14,16]. It is unclear whether these findings
can be generalized to pregnant women, especially as pregnant
women display different behavioral patterns (e.g. reduced physical
activity, more sitting, lying, sleeping, and slower walking pace)
[22–24], altered cortisol levels, and altered cortisol responses to
stress [5,25,26] compared to nonpregnant controls or to nonpreg-
nant state. To our knowledge, it has not yet been investigated in a
sample of pregnant women whether informing them about
objective compliance monitoring improves compliance with
scheduled saliva sampling, or whether noncompliance biases
cortisol estimates. Moreover, to our knowledge, whether acoustical
reminders improve saliva-sampling compliance has not yet been
experimentally tested at all.
The goals of the present study were a) to estimate compliance
rates with a standard ambulatory saliva-sampling protocol; b) to
estimate whether the strategies of informing subjects about
objective compliance monitoring and using acoustical reminders
improve compliance with scheduled saliva sampling; and c) to
estimate the association between saliva-sampling noncompliance
and saliva cortisol concentrations in pregnant women.
Methods
Ethics Statement
The study was conducted in accordance with the Declaration of
Helsinki and approved by the ethics committees of Basel
(Ethikkommission beider Basel, Basel, Switzerland) and Zurich
(Kantonale Ethikkommission Zuerich, Zuerich, Switzerland). All
participants gave written informed consent.
Subjects
We recruited pregnant women during antenatal visits at the
outpatient service of the Department of Obstetrics, University
Hospital Zurich, Switzerland. Eligible women were in their 12th to
32nd week of gestation, had sufficient German language skills, and
underwent regular antenatal visits at the outpatient service.
Exclusion criteria were diseases potentially affecting the neuroen-
docrine system, high-risk pregnancy, human immunodeficiency
virus (HIV) infection, and the use of hormone-containing
medication. These criteria were chosen to minimize distortions
in the women’s cortisol concentrations.
Experimental interventions and design
We told all the women to collect eight saliva samples on two
consecutive days. Scheduled sampling times were: 0, 30, 45, and
60 min after awakening, and at 1100, 1500, 2000, and 2200 h.
Objective compliance with the time of sampling was monitored, in
all women, with a hidden Medication Event Monitoring System
(MEMS 6 TrackCap Monitor, Aardex Ltd., Switzerland). Two
interventions were tested by creating four experimental groups:
Group 1 received information about the objective compliance
monitoring at the beginning of the study and received timers
(Kuechentimer, Zyliss, Switzerland) and alarm clocks (basic alarm
clock, Intertronic, Switzerland) to provide acoustical reminders at
the scheduled sampling times. The second group received only the
information about the objective compliance monitoring. The third
group received the acoustical reminders alone, and the fourth
group received neither the information about the objective
compliance monitoring nor acoustical reminders. Women in the
groups receiving the acoustical reminders were advised to use the
timer to time the samples at +30, +45, and +60 min after
awakening and the clock to time the 1100 h, 1500 h, 2000 h, and
2200 h samples, even if they possessed their own watch.
In sum, a randomized 2 (disclosure intervention: informed vs.
noninformed)62 (reminder intervention: acoustical reminders vs.
no acoustical reminders)62 (days)68 (sampling times) design was
applied. A blocked randomization sequence was created with a
computerized random number generator and applied with a
1:1:1:1 assignment to the four experimental groups. Study
collaborators using sealed envelopes conducted the assignment.
All women were blinded to the true nature of the present study;
laboratory staff analyzing the saliva samples were blinded to the
women’s experimental group assignment.
Procedure
During an antenatal visit, obstetricians told women who met the
inclusion criteria about the study. A study collaborator gave
standardized information to interested women. Women who
agreed to participate were assigned to the experimental groups as
described above and received packages with the respective study
materials. A study collaborator, stressing the importance of high
compliance with the sampling protocol, explained the use of the
material in detail. The women were instructed to collect saliva
samples on two consecutive days right before their next scheduled
antenatal visit. Three days before sampling, a study collaborator
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contacted them by telephone as a reminder and to answer any
questions. The women provided demographic information,
including age, height, employment status, number of hours
worked per week, prepregnancy body weight, current body
weight, gestational age of their fetus, gravidity, and parity, via
questionnaire. They were instructed not to brush their teeth, eat,
consume caffeine, or smoke during the first hour after awakening
and 1 h before each scheduled saliva sampling. They were also
advised to avoid physical exercise but to otherwise follow their
daily routine. These restrictions were meant to minimize
distortions in the women’s cortisol concentrations. The women
handed over the study material to a study collaborator the day
after sampling, at the antenatal visit. On this occasion, we asked
the women, by questionnaire, whether there was anything that
had attracted particular attention or was particularly noticeable
during the study. In doing so, we sought to test whether
noninformed women obtained knowledge about objective com-
pliance monitoring. Finally, the women were debriefed about the
true nature of the study.
Saliva sampling
Straws and 2.0-mL safe-lock tubes (Eppendorf, Hamburg,
Germany), labeled with scheduled sampling time, were clearly
arranged until usage in a transparent MediDispenser (Wiegand,
Buelach, Switzerland). Women were instructed to place the tubes
immediately after saliva sampling into small nontransparent
medicine containers (Wiegand, Buelach, Switzerland) fitted with
MEMS 6 caps. As a cover story, all the women were told that this
procedure was important to maintain sample quality by minimiz-
ing light exposure. For the same reason, they were advised to open
the medicine container only to insert the saliva samples. This
container was to be stored overnight and, when possible, in a
refrigerator.
Biochemical analyses
We froze returned saliva samples at 220uC until biochemical
analysis. Thawed samples were centrifuged at 3000 g for 10 min.
Salivary free cortisol was analyzed using a commercial enzyme
immunoassay for human saliva (cortisol ELISA, IBL, Hamburg,
Germany). Analytical assay sensitivity was 2.0 pg/mL. The intra-
and interassay coefficients of variation were #7.3% and #9.3%,
respectively.
Compliance with saliva sampling
We assessed self-reported and objective compliance with
scheduled saliva-sampling times. Self-reported compliance was
assessed with a paper-and-pencil diary, in which the women were
asked to record the exact time and date of each saliva sampling.
Objective compliance was assessed with the MEMS 6 caps that
recorded the moment of each opening and closing of the medical
container. The opening times of the MEMS 6 caps were processed
with PoverView (Aardex Ltd., Switzerland). Compliance criteria
were adapted from Kudielka et al. [14] and applied for both self-
report and objective compliance. Accordingly, we classified the
+0-min sample as compliant if collected within 610 min of the
self-reported wake-up time, the +30-, +45-, and +60-min samples
as compliant if collected within 67 min, and the 1100 h, 1500 h,
2000 h, and 2200 h samples as compliant if collected within 61 h
of the scheduled sampling time. In the case of multiple MEMS 6
cap openings around the scheduled sampling times, we selected
the most compliant. If a women delivered more saliva samples
than recorded MEMS 6 cap opening times, we selected the most
compliant opening times for the delivered samples and classified
the remaining samples as noncompliant.
Statistical analyses
In the first set of analyses, we estimated the association of the
two interventions with objective compliance using general linear
models (GLMs). Disclosure intervention (informed vs. nonin-
formed) and reminder intervention (acoustical reminders vs. no
acoustical reminders) were the two fixed independent factors, and
objective compliance (percentage of compliant samples) was the
dependent variable. The +0-min samples were excluded, as we
could not objectively determine whether the women reported their
wake-up times accurately. We repeated the analysis described
above with objective morning compliance (+30-, +45-, and +60-
min samples only; percentage of compliant samples) as the
dependent variable. High compliance with the morning samples
is considered especially important as the cortisol awakening
response (CAR) is often used for research purposes as indicator
of HPA reactivity [11]. The CAR represents the rapid steep
increase of cortisol concentrations within the first 30 min of
awakening [11,27].
In the second set of analyses, we estimated the association of
objective compliance with saliva cortisol concentrations using a
random coefficient model, a type of linear mixed model [28]. This
type of model has been shown to provide more efficient and less
biased results in data where missing values occur, compared with
complete case analyses or analyses in which missing values are
imputed using the last observation carried forward method [29].
Further, linear mixed models do not require omitting subjects with
missing data from the analyses, thereby minimizing data loss and
risk of bias while increasing power. Our model included a random
intercept as well as a random slope parameter when this improved
model fit (based on Akaike’s Information Criterion, AIC) [28].
The random coefficient model allowed us to differentiate
between objective state and trait compliance. Trait compliance
is a time-invariant predictor and measuring it allowed us to
estimate whether the women’s objective compliance with the
sampling schedule was associated with their diurnal profiles of
cortisol concentrations. We estimated the effect of the women’s
objective compliance by dividing the women into a low (0–5
compliant samples; 0–31% of all scheduled samples), a moderate
(6–12 compliant samples; .31–80%), and a high (13–16
compliant samples; .80–100%) compliance group. We used the
categorical compliance predictor instead of the continuous
compliance predictor ‘‘number of compliant samples’’ because
preliminary analyses revealed better model fits for the former. For
the high compliance group, we chose the 80% cut-off because
prior research used this cut-off to classify compliance in a cortisol-
sampling protocol [30] and because medical research usually
classifies patients with compliance of more than 80% as compliant
[30,31]. To enlarge the small sample size in the low compliance
group, we chose a 31% cut-off (0–5 compliant samples) instead of
the 20% cut-off applied by Hall et al. [30]. For the predictor time
we assumed linear trajectories for each of two intervals covering
the time points +0- to +30-min and +30-min to the last time point
(2200 h), respectively.
State compliance relates to individual saliva samples and
allowed us to estimate whether a deviation from a scheduled
sampling time was associated with the cortisol concentration
measured in the related sample. We estimated this association by
entering the time-varying predictor ‘‘deviation from scheduled
sampling time in minutes’’ into our model. Again, we excluded the
+0-min samples for the same reasons as stated above. The
predictor time was again assumed to be linear, but we only
considered the interval +30-min to 2200 h. We repeated our
mixed model analyses, adjusting for several a priori defined
potential time-invariant confounders, including the continuous
Increasing Saliva Sampling Compliance
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covariates age, gestational age of fetus, parity [32], and current
body weight [33].
The percentage of compliant samples was arcsine transformed,
cortisol data were square root transformed, and deviations from
scheduled sampling times in minutes were log transformed to
approximate normal distributions. An alpha level of 0.05
determined statistical significance. Data analysis was carried out
using IBM SPSS Statistics 20 for Mac OS X.
Results
We included 75 eligible women in the present study. Six women
declined further participation before saliva sampling. Two women
were excluded because of a MEMS 6 cap defect and two because
they collected saliva samples without using the MEMS 6 caps.
Another woman was excluded because she took part only on the
first day of the study because she delivered prematurely on the
second day. Thus, the final sample consisted of 64 women.
Demographic information is presented in Table 1. None of the
noninformed women reported any knowledge of the objective
compliance monitoring on the questionnaire before the debriefing.
Compliance with the saliva-sampling protocol and
interventions
Self-reported compliance and objective compliance refer to all
samples (+30-, +45-, +60-min, 1100 h, 1500 h, 2000 h, and
2200 h samples), and objective morning compliance refers to the
+30-, +45-, and +60-min samples only. Across all the women, self-
reported compliance with the saliva-sampling protocol was 91%
and objective compliance was 70%. Self-reported compliance was
high in all experimental groups (range 88–94%). Objective
compliance was highest in the informed group without acoustical
reminders (86%) and lowest in the noninformed group without
acoustical reminders (58%). The women’s objective morning
compliance was lower (59%) compared to their objective
compliance reported above (70%). Moreover, self-reported com-
pliance in women with low objective compliance (0–31%
compliant samples) was 80%. Descriptive compliance data are
presented in Table 2.
Objective compliance in informed and noninformed women
was 81% and 60%, and in women with and without acoustical
reminders 68% and 72%, respectively. The GLM showed
significant main effects of disclosure intervention (informed vs.
noninformed) on both objective compliance, F(1,60) = 17.64,
p,0.001, and objective morning compliance, F(1,60) = 9.27,
p=0.003. However, there was no significant main effect of
reminder intervention (acoustical reminders vs. no acoustical
reminders) on either compliance type [objective compliance,
F(1,60) = 0.78, p=0.379; objective morning compliance, F(1,60)
= 0.80, p=0.374]. Interaction effects between disclosure interven-
tion and reminder intervention were also nonsignificant for both
Table 1. Demographic variablesa across experimental groups.
Variable Total Compliance monitoring
(n=64) Informed Noninformed
Acoustical reminders Acoustical reminders
With Without With Without
(n=16) (n=17) (n=15) (n=16)
Age (years) 33 (28;36) 33 (27;39) 33 (28;35) 34 (32;40) 31 (26;35)
Height (cm) 167 (163;172) 163 (162;172) 164 (161;170) 170 (166;173) 168 (165;172)
Employedb
Yes 45 (70.3) 10 (62.5) 14 (82.4) 9 (60) 12 (75)
No 16 (25) 5 (31.3) 2 (11.8) 5 (33.3) 4 (0)
Unknown 3 (4.7) 1 (6.3) 1 (5.9) 1 (6.7) 0 (0)
Hours worked per week 28 (17;42) 35 (11;42) 25 (15;41) 40 (20;51) 28 (24;42)
Prepregnancy body weight (kg) 60 (56;68) 59 (56;71) 59 (54;64) 61 (58;69) 59 (55;67)
Current body weight (kg) 70 (62;75) 67 (63;76) 68 (58;74) 71 (64;85) 72 (60;75)
Gestational age of fetus 26 (17;31) 26 (16;30) 22 (17;31) 29 (21;34) 24 (17;29)
Gravidityb
0 28 (43.8) 7 (43.8) 6 (35.3) 6 (40) 9 (56.3)
1–2 21 (32.8) 4 (25) 6 (35.3) 5 (33.4) 6 (37.5)
$3 9 (14.2) 2 (12.6) 3 (17.7) 3 (20) 1 (6.3)
Unknown 6 (9.4) 3 (18.8) 2 (11.8) 1 (6.7) 0 (0)
Parityb
0 34 (53.1) 9 (56.3) 8 (47.1) 7 (46.7) 10 (62.5)
1–2 21 (32.8) 3 (18.8) 6 (35.3) 6 (40) 6 (37.5)
$3 3 (4.7) 1 (6.3) 1 (5.9) 1 (6.7) 0 (0)
Unknown 6 (9.4) 3 (18.8) 2 (11.8) 1 (6.7) 0 (0)
aIf not otherwise specified, median (25 percentile; 75 percentile) is reported.
bNumber of pregnant women (percent) is reported.
doi:10.1371/journal.pone.0086204.t001
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compliance types [objective compliance, F(1,60) = 2.46, p=0.122;
objective morning compliance, F(1,60) = 0.77, p=0.385].
Objective compliance and cortisol concentrations
Objective compliance information was used to estimate the
associations between compliance with scheduled sampling and
cortisol concentrations.
Cortisol concentrations in high-, moderate-, and low-
compliance women. Twenty-eight women (44%) showed high
objective compliance with the saliva-sampling protocol, 29 (45%)
moderate objective compliance, and seven (11%) low objective
compliance. Using random coefficient models, we compared the
cortisol concentrations of women with high, moderate, and low
objective compliance. We found a main effect for objective
compliance on cortisol concentrations, F(2,64) = 8.22, p,0.001,
which was due almost entirely to the difference in cortisol
concentrations between objective low-compliance women on the
one hand and the combined objective moderate- and high-
compliance women on the other, F(1,74) = 16.14, p,0.001, for
contrast. However, there was no difference in cortisol concentra-
tions between objective moderate- and high-compliance women,
F(1,63) = 0.41, p=0.525. We also found an interaction effect
between objective compliance and time of saliva measurement on
cortisol concentrations, F(2,64) = 5.26, p = 0.008. As shown in
Figure 1, cortisol levels of women in the low-compliance group
were lower than cortisol levels of women in the moderate- and
high-compliance groups, but this effect slowly disappeared
throughout the day, such that at the 2200 h scheduled sampling
time, women at the three levels of compliance displayed
comparable cortisol levels. Accordingly, if we considered morning
cortisol concentrations only (+0-, +30-, +45-, and +60-min
samples), we still found a main effect of objective compliance on
morning cortisol concentrations, F(2,64) = 10.24, p,0.001.
Intraindividual variation in these morning concentrations is
indicative of the CAR. The associations stated above did not
change significantly after adjustment for age, current body weight,
gestational age of fetus, and parity (data available on request).
Deviation from scheduled sampling and the cortisol
concentration in the related sample. A total of 753 saliva
samples were included in this analysis. An objective deviation from
a scheduled sampling time was associated with the cortisol level
measured in the related sample, F(1,705) = 7.38, p=0.007; that is,
the longer the time delay from a scheduled sampling, the lower the
cortisol level. The cortisol levels (on the square-root scale)
decreased per minute deviation (on the natural logarithm scale)
by a value of 0.82 (SE 0.30). The nonsignificant interaction effect
between deviation from scheduled sampling time and time of
Table 2. Self-reported and objective compliance with scheduled saliva sampling across experimental groups.
Descriptive data Self-reported compliance Objective compliance
Informed Non-informed Total Informed Non-informed Total
Acoustical reminders Acoustical reminders Acoustical reminders Acoustical reminders
With Without With Without With Without With Without
(n=15) (n=16) (n=14) (n=15) (n=60)a (n=16) (n=17) (n=15) (n=16) (n=64)
Morning samplesb
Number of scheduled samples 90 96 84 90 360 96 102 90 96 384
Number of compliant samples 73 88 76 74 311 60 76 43 46 225
Compliant samples in % (SD) 81% (25.9) 92% (25.1) 90% (18.2) 82% (30.5) 86% (25.2) 62% (24.0) 75% (25.1) 48% (28.8) 48% (30.3) 59% (28.8)
All samplesc
Number of scheduled samples 210 224 196 210 840 224 238 210 224 896
Number of compliant samples 185 210 177 192 764 168 204 129 130 631
Compliant samples in % (SD) 88% (13.4) 94% (12.2) 90% (21.3) 91% (13.5) 91% (15.1) 75% (20.2) 86% (16.4) 61% (25.6) 58% (25.5) 70% (24.3)
Summed absolute deviations from scheduled sampling times in minutesc
Median 34 51 53 25 47 145 92 248 185 147
25th percentile; 75th percentile 12; 120 28; 92 40; 107 0; 80 15; 99 60, 281 56, 190 147; 553 87; 369 74; 274
aNumber in sample for self-reported compliance is four less than number in sample for objective compliance because of missing data in self-report questionnaires.
bIncluding the +30-min, +45-min, and +60-min samples on two consecutive days.
cIncluding the +30-min, +45-min, +60-min samples and the 1100 h, 1500 h, 2000 h, and 2200 h samples on two consecutive days.
SD, standard deviation.
doi:10.1371/journal.pone.0086204.t002
Figure 1. Cortisol concentrations in women with low, moder-
ate, and high compliance. Saliva cortisol concentrations were
averaged across two sampling days representing estimated values
from a linear mixed model.
doi:10.1371/journal.pone.0086204.g001
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saliva measurement on cortisol concentrations, F(1,713) = 2.50,
p=0.115, indicated a stable association of deviation from
scheduled sampling time with cortisol concentrations throughout
the day. The associations stated above did not change significantly
after adjustment for age, current body weight, gestational age of
fetus, and parity (data available on request).
Discussion
Objective noncompliance with scheduled saliva sampling was
associated with biased cortisol estimates in pregnant women.
Informing women about the compliance monitoring improved
objective compliance with scheduled saliva sampling. In contrast,
the use of acoustical reminders had no effect on objective
compliance.
Compliance with the saliva-sampling protocol
The women’s self-reported compliance was higher than their
objective compliance with the saliva-sampling protocol, especially
when they were not informed about the compliance monitoring.
Even the women with low objective compliance (0–31% compliant
samples) self-reported, on average, high compliance. These
findings are in line with prior studies in nonpregnant subjects
showing a possible bias in self-reported saliva-sampling compliance
[13–15].
In the present study, women informed about compliance
monitoring displayed objective compliance rates of 75% (with
acoustical reminders) and 86% (without acoustical reminders). By
comparison, prior studies found objective compliance rates in
informed subjects of 89–97% [13,14]. Objective compliance rates
in our noninformed women were 61% (with acoustical reminders)
and 58% (without acoustical reminders). In contrast, noninformed
subjects in prior studies had objective compliance rates of 62–84%
[13,14]. Several reasons may explain our somewhat lower
objective compliance rates compared to the prior studies: First,
there may be specific behavioral patterns in pregnant women [22–
24]. Second, there is the issue of saliva-sampling burden. Kudielka
et al. [16] hypothesized that a higher sampling burden related to
the number of scheduled saliva samples per day may lead to lower
saliva-sampling compliance. In line with this, the daily saliva-
sampling burden in the present study (eight samples per day) was
higher than that in the studies of Kudielka et al. (six samples per
day; [14]) and Broderick et al. (five samples per day; [13]). Third,
other differences in study design may account for lower
compliance rates in the present study (e.g. we applied more
conservative compliance criteria regarding the morning samples
compared to Broderick et al.) [13]. Moreover, we cannot exclude
further factors in pregnant women associated with lower objective
saliva-sampling compliance.
Associations of the interventions with objective
compliance
In this randomized controlled trial, the disclosure intervention
(informing about compliance monitoring) was associated with
higher objective compliance with the saliva-sampling protocol.
This finding is in line with prior studies in nonpregnant subjects
[13,14] and suggests that informing about compliance monitoring
improves saliva-sampling compliance in pregnant women. Thus,
the present study extends earlier results to a sample of pregnant
women. In the present study, informing the women was associated
with higher objective compliance with respect to both all
scheduled samples and the scheduled morning samples. High
compliance with the morning samples is particularly relevant
because the CAR has been used extensively as an indicator of
HPA activity, and because the CAR is increasingly relevant in
endocrine research in pregnant women (e.g., [7,26,34,35]).
In contrast, we did not find any positive effect of the reminder
intervention on objective compliance. Using acoustical reminders
was not associated with improved objective saliva-sampling
compliance. One possible explanation for this observation is that
carrying timers and alarm clocks was rather inconvenient. Indeed,
several women reported this during the debriefing at the end of the
study. To our knowledge, the present study is the first to
investigate the association of acoustical reminders with saliva-
sampling compliance. However, in the research field of antiret-
roviral therapy in HIV treatment, a review described that the use
of electronic reminders improved medication compliance in four
of eight studies [20]. This review, however, included studies
relying on self-report measures. In a recent randomized controlled
trial, the use of pocket digital alarms had no effect on objective
medication compliance, as measured by the percentage of
dispensed drug doses [36]. Thus, in line with the latter, our data
discourages the use of acoustical reminders to improve saliva-
sampling compliance in pregnant women: While having no
positive effect on compliance, the use of acoustical reminders
increases the study burden on women and generates additional
study costs.
Associations of objective compliance with cortisol
concentrations
The women’s objective compliance with the saliva-sampling
protocol was associated with their cortisol concentrations. Women
with low compliance displayed lower cortisol levels compared to
those with moderate or high compliance. In detail, women with
low compliance showed lower CARs and downward-shifted day
slopes of cortisol compared to women with moderate and high
compliance. One explanation could be that women with low
compliance deliver samples more often with a delay, which – due
to the diurnal decline of cortisol concentrations – is likely to be
associated with lower cortisol levels, resulting in lower levels on
average. Alternatively, being low compliant may be related to
certain trait characteristics, which in turn may be associated with
lower cortisol levels. Cortisol levels did not differ between women
with moderate and high compliance. Hence, low compliance may
bias cortisol estimates, but moderate compliance may have less
impact. The finding that noncompliance may bias cortisol results is
in line with prior studies in nonpregnant subjects [13,14,16].
Without objective compliance monitoring, we would not have
been able to identify the biased cortisol estimates of women with
low compliance, as they incorrectly self-reported high compliance.
Thus, without objective compliance information, cortisol slopes or
CARs, biased by low compliance, could lead to invalid interpre-
tations. For example, prior research has associated lower morning
cortisol levels with cumulative stress in pregnant women [37].
Without objective compliance information, it might be difficult to
conclude whether lower morning cortisol levels are directly
associated with cumulative stress or with a bias introduced by
saliva-sampling noncompliance related to stress (compare [14]). In
the present study, the association between women’s objective
compliance and their cortisol levels decreased through the day.
This finding could be important as prior research used late
afternoon or evening cortisol data instead of the CAR to examine
specific research questions in pregnant women [38,39]. Based on
our findings, when objective compliance information is not
available, using evening samples may reduce the potential bias
in cortisol estimates introduced by noncompliance.
In the present study, women’s compliance was associated with
their diurnal profiles of cortisol concentrations. Moreover, we
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observed altered cortisol levels in less-compliant samples. The
larger a time delay from a scheduled saliva sampling, the stronger
was the bias by reduced cortisol levels. This finding confirms the
importance of saliva-sampling compliance in pregnant women.
Limitations and strengths
The present study has several limitations. First, the sample size
of our low-compliance group was small. Hence, our findings
should be replicated in a larger sample. Second, the following
hampered calculating a priori power analyses: To our knowledge,
the present study is the first to estimate whether acoustical
reminders improve saliva-sampling compliance; hence, estimation
of effect sizes was difficult. Moreover, power analysis for mixed
models requires information regarding estimates of intraclass
correlations, which were not available in our case. Third, we could
not control whether the women actually used the acoustical
reminders. Thus, the nonsignificant association between reminder
intervention and saliva-sampling compliance could be due to
women not having applied the intervention (compare [36]).
However, we were less interested in whether the use of acoustical
reminders improved compliance, but mainly interested in whether
the distribution of acoustical reminders and the recommendation
of their use improved compliance. Fourth, without actigraph
monitoring, we could not objectively define whether women
reported their wake-up times accurately. However, evidence
suggests that self-reported wake-up times are reasonably accurate,
compared with objectively measured wake-up times [40,41]. Fifth,
women may have collected saliva samples at scheduled times
without storing them in the MEMS container. Putting several
compliant saliva samples into the MEMS container at the same
time would have led to missing MEMS 6 cap opening times and,
thus, to objective compliant samples being classified as noncom-
pliant. In the present study, this would have led to an
underestimation of objective compliance rates. Last, findings
regarding acoustical reminders may not be generalizable to other
reminder systems. Further studies might examine whether other
reminder systems (e.g. handheld computers, mobile apps) improve
saliva-sampling compliance.
Despite the study’s limitations, the present study has important
strengths. First, we applied a standard two-day ambulatory saliva-
sampling protocol, and second, we used a randomized controlled
trial to test strategies to improve saliva-sampling compliance.
Third, we used mixed model analyses to estimate the associations
between compliance and cortisol concentrations. Mixed model
analysis is considered the method of choice for analyzing
ambulatory saliva cortisol data [11].
Conclusions
Our study findings indicate that informing about the use of
objective compliance monitoring substantially improved saliva-
sampling compliance in pregnant women. In contrast, using
acoustical reminders had no positive effect. They should inform
future studies examining cortisol in pregnant women within
ambulatory saliva-sampling designs and are highly important for
several reasons. First, noncompliance with a standard ambulatory
saliva-sampling protocol was common in pregnant women and
occurred more frequently than in prior studies with nonpregnant
subjects. Second, noncompliant women could not be identified by
self-report data. Third, objective noncompliance biased estimates
of women’s cortisol concentrations and, hence, may have led to
invalid interpretations. Thus, the present study encourages using
objective compliance monitoring to identify noncompliance with a
saliva-sampling protocol in pregnant women. Moreover, it
suggests informing women about objective compliance monitoring
to improve compliance.
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